Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Wilhelmine H Meeraus, Bailey M DeBarmore, Hana Mullerova, William A Fahy & Victoria S Benson. (2021) Terms and Definitions Used to Describe Recurrence, Treatment Failure and Recovery of Acute Exacerbations of COPD: A Systematic Review of Observational Studies. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3487-3502.
Read now
Read now
Jean Bourbeau, Mona Bafadhel, Neil C Barnes, Chris Compton, Valentina Di Boscio, David A Lipson, Paul W Jones, Neil Martin, Gudrun Weiss & David M G Halpin. (2021) Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 499-517.
Read now
Read now
Wilhelmine H Meeraus, Hana Mullerova, Céline El Baou, Marion Fahey, Edith M Hessel & William A Fahy. (2021) Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 225-244.
Read now
Read now
Jenny Tse, Keiko Wada, Yi Wang, Dominic Coppolo, Vladimir Kushnarev & Jason Suggett. (2020) Impact of Oscillating Positive Expiratory Pressure Device Use on Post-Discharge Hospitalizations: A Retrospective Cohort Study Comparing Patients with COPD or Chronic Bronchitis Using the Aerobika® and Acapella® Devices. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2527-2538.
Read now
Read now
Dave Singh, Leonardo M Fabbri, Stefano Vezzoli, Stefano Petruzzelli & Alberto Papi. (2019) Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 531-546.
Read now
Read now
Xiao Liu, Jingge Qu, Weixiao Xue, Liangai He, Jun Wang, Xuejiao Xi, Xiaoxia Liu, Yunhong Yin & Yiqing Qu. (2018) Bioinformatics-based identification of potential microRNA biomarkers in frequent and non-frequent exacerbators of COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1217-1228.
Read now
Read now
Anne Pernille Toft-Petersen, Christian Torp-Pedersen, Ulla Møller Weinreich & Bodil Steen Rasmussen. (2016) Assisted ventilation in COPD – association between previous hospitalizations and mortality. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 935-943.
Read now
Read now
Yin Wan, Shawn X Sun, Shelby Corman, Xingyue Huang, Xin Gao & Andrew F Shorr. (2015) A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2127-2136.
Read now
Read now
Jetty A. Overbeek, Fernie J.A. Penning-van Beest, Maria-Magdalena Balp, P.N. Richard Dekhuijzen & Ron M.C. Herings. (2015) Burden of Exacerbations in Patients with Moderate to Very Severe COPD in the Netherlands: A Real-life Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 12:2, pages 132-143.
Read now
Read now
Articles from other publishers (26)
Barathi Bakthavatsalu, Catherine Walshe & Jane Simpson. (2022) The experience of hospitalization in people with advanced chronic obstructive pulmonary disease: A qualitative, phenomenological study. Chronic Illness 19:2, pages 339-353.
Crossref
Crossref
Huanrong Ruan, Hailong Zhang, Jiajia Wang, Hulei Zhao, Weihong Han & Jiansheng Li. (2023) Readmission rate for acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis. Respiratory Medicine 206, pages 107090.
Crossref
Crossref
A Kristensen, P Sivapalan, K Bagge, T Biering-Sørensen, R Sørensen, J Eklöf & JUS Jensen. (2022) Association between anticoagulant therapy, exacerbations and mortality in a Danish cohort of patients with Chronic Obstructive Pulmonary Disease. Science Progress 105:2, pages 003685042211043.
Crossref
Crossref
Hana Müllerová, Jonathan Marshall, Enrico de Nigris, Precil Varghese, Nick Pooley, Nina Embleton, Clementine Nordon & Zoe Marjenberg. (2022) Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis. Therapeutic Advances in Respiratory Disease 16, pages 175346662211136.
Crossref
Crossref
Svetlana I. Ovcharenko & Andrey S. Belevskiy. (2021) Benefit/risk ratio profile of single inhaler triple therapy for сhronic obstructive pulmonary disease patients. PULMONOLOGIYA 31:5, pages 645-652.
Crossref
Crossref
Kevin J. O’Sullivan, Valerie Power, Barry Linnane, Deirdre McGrath, Hilda Fogarty, Martina Ryan, Rebecca White, Conor Noonan, Eithne Mulloy, Leonard W. O’Sullivan & Colum P. Dunne. (2021) An initial evaluation of the safety of a disposable oscillating positive expiratory pressure device in patients with chronic obstructive pulmonary disease: a short-term pilot study. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Erin R. Camac, Helen Voelker & Gerard J. Criner. (2021) Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life. Respiratory Medicine 186, pages 106526.
Crossref
Crossref
Meng-Ting Wang, Jyun-Heng Lai, Ya-Ling Huang, Feng-Chih Kuo, Yun-Han Wang, Chen-Liang Tsai & Min-Yu Tu. (2020) Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case–control study. Respiratory Research 21:1.
Crossref
Crossref
Chidiamara M. Njoku, Jaber S. Alqahtani, Barbara C. Wimmer, Gregory M. Peterson, Leigh Kinsman, John R. Hurst & Bonnie J. Bereznicki. (2020) Risk factors and associated outcomes of hospital readmission in COPD: A systematic review. Respiratory Medicine 173, pages 105988.
Crossref
Crossref
Qiangru Huang, Chengying He, Huaiyu Xiong, Tiankui Shuai, Chuchu Zhang, Meng Zhang, Yalei Wang, Lei Zhu, Jiaju Lu & Liu Jian. (2020) DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMJ Open 10:10, pages e037923.
Crossref
Crossref
I. V. Demko, L. M. Kudelya, E. A. Sobko, I. A. Solov'eva, I. N. Trofimenko, A. V. Tetenevа, A. A. Grebenyuk, N. G. Ganyukova, N. S. Gyrgeshkinova, S. A. Luk'yanov, Ch. Ch. Mandarzhap & O. A. Meshcheryakova. (2020) Diagnostic and treatment options for patients with COPD as part of real clinical practice. Approaches to the treatment of patients with various phenotypes according to GOLD (2019): materials of the Council of Experts of the Siberian Federal District, Chita and Buryatia, dated 03.15.19. Russian Pulmonology 30:2, pages 245-251.
Crossref
Crossref
Yamely Mendez, Francisco E. Ochoa-Martinez & Tatiana Ambrosii. (2019) Chronic Obstructive Pulmonary Disease and Respiratory Acidosis in the Intensive Care Unit. Current Respiratory Medicine Reviews 15:2, pages 79-89.
Crossref
Crossref
Katy C. Norman, Christine M. Freeman, Neha S. Bidthanapally, MeiLan K. Han, Fernando J. Martinez, Jeffrey L. Curtis & Kelly B. Arnold. (2019) Inference of Cellular Immune Environments in Sputum and Peripheral Blood Associated with Acute Exacerbations of COPD. Cellular and Molecular Bioengineering 12:2, pages 165-177.
Crossref
Crossref
Sapna Bhatia & Akshay Sood. 2019. Mechanisms and Manifestations of Obesity in Lung Disease. Mechanisms and Manifestations of Obesity in Lung Disease
67
87
.
Alexis Gerber, Catriona Moynihan, Sharon Klim, Peter Ritchie & Anne-Maree Kelly. (2018) Compliance with a COPD bundle of care in an Australian emergency department: A cohort study. The Clinical Respiratory Journal 12:2, pages 706-711.
Crossref
Crossref
Romain Kessler, Pere Casan-Clara, Dieter Koehler, Silvia Tognella, Jose Luis Viejo, Roberto W. Dal Negro, Salvador Díaz-Lobato, Karina Reissig, José Miguel Rodríguez González-Moro, Gilles Devouassoux, Jean-Michel Chavaillon, Pierre Botrus, Jean-Michel Arnal, Julio Ancochea, Anne Bergeron-Lafaurie, Carlos De Abajo, Winfried J. Randerath, Andreas Bastian, Christian G. Cornelissen, Georg Nilius, Joëlle B. Texereau & Jean Bourbeau. (2018)
COMET: a multicomponent home-based disease-management programme
versus
routine care in severe COPD
. European Respiratory Journal 51:1, pages 1701612.
Crossref
Crossref
Katrine P. Lindvig, Anne C. Brøchner, Annmarie T. Lassen & Søren Mikkelsen. (2017) Prehospital prognosis is difficult in patients with acute exacerbation of chronic obstructive pulmonary disease. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 25:1.
Crossref
Crossref
Preben Ulrich Pedersen, Karen Bagger Ersgard, Tina Brandt Soerensen & Palle Larsen. (2017) Effectiveness of structured planned post discharge support to patients with chronic obstructive pulmonary disease for reducing readmission rates: a systematic review. JBI Database of Systematic Reviews and Implementation Reports 15:8, pages 2060-2086.
Crossref
Crossref
Jørgen Vestbo, Alberto Papi, Massimo Corradi, Viktor Blazhko, Isabella Montagna, Catherine Francisco, Géraldine Cohuet, Stefano Vezzoli, Mario Scuri & Dave Singh. (2017) Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial. The Lancet 389:10082, pages 1919-1929.
Crossref
Crossref
Anne Pernille Toft-Petersen, Christian Torp-Pedersen, Ulla Møller Weinreich & Bodil Steen Rasmussen. (2017) Trends in assisted ventilation and outcome for obstructive pulmonary disease exacerbations. A nationwide study. PLOS ONE 12:2, pages e0171713.
Crossref
Crossref
Timm Greulich, Christoph Nell, David Hohmann, Marco Grebe, Sabina Janciauskiene, Andreas Rembert Koczulla & Claus Franz Vogelmeier. (2017)
The prevalence of diagnosed α
1
-antitrypsin deficiency and its comorbidities: results from a large population-based database
. European Respiratory Journal 49:1, pages 1600154.
Crossref
Crossref
Dave Singh, Alberto Papi, Massimo Corradi, Ilona Pavlišová, Isabella Montagna, Catherine Francisco, Géraldine Cohuet, Stefano Vezzoli, Mario Scuri & Jørgen Vestbo. (2016) Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial. The Lancet 388:10048, pages 963-973.
Crossref
Crossref
C Echevarria, J Steer, K Heslop-Marshall, SC Stenton, PM Hickey, R Hughes, M Wijesinghe, RN Harrison, N Steen, AJ Simpson, GJ Gibson & SC Bourke. (2016) Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax 71:2, pages 133-140.
Crossref
Crossref
Joanna Wai Yinn Chow, Keshav Khullar, Kashyap Katechia, Sharon Klim & Anne-Maree Kelly. (2016) Controlled oxygen therapy at emergency department presentation increases the likelihood of achieving target oxygen saturations in patients with exacerbations of chronic obstructive pulmonary disease. Emergency Medicine Australasia 28:1, pages 44-47.
Crossref
Crossref
Kunal Srivastava, Deepika Thakur, Sheetal Sharma & Yogesh Suresh Punekar. (2015) Systematic Review of Humanistic and Economic Burden of Symptomatic Chronic Obstructive Pulmonary Disease. PharmacoEconomics 33:5, pages 467-488.
Crossref
Crossref
Sigrun Alba Johannesdottir Schmidt, Martin Berg Johansen, Morten Olsen, Xiao Xu, Joseph M Parker, Nestor A Molfino, Timothy L Lash, Henrik Toft Sørensen & Christian Fynbo Christiansen. (2014) The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study. BMJ Open 4:12, pages e006720.
Crossref
Crossref